查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413091

奈米醫學市場：按分子類型、形態、應用和適應症分類 - 全球預測 2024-2030

Nanomedicine Market by Molecule Type (Nanodevices, Nanoparticles, Nanoshells), Modality (Diagnostics, Treatment), Application, Indication - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年奈米藥物市場規模為2,062.5億美元，預估2024年將達2,273.7億美元，2030年將達4,258.8億美元，複合年成長率為10.91%。

全球奈米醫學市場

主要市場統計
基準年[2023] 2062.5億美元
預測年份 [2024] 2273.7億美元
預測年份 [2030] 4258.8億美元
複合年成長率（%） 10.91%
奈米醫學市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估奈米醫學市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對奈米醫學市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-奈米醫學市場的市場規模和預測是多少？

2-奈米醫學市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-奈米醫學市場的技術趨勢和法律規範是什麼？

4-奈米醫學市場主要廠商的市場佔有率是多少？

5-進入奈米醫藥市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的流行和有效治療的需求
      • 利用奈米醫學技術進行個人化醫療
      • 在體外診斷和體內成像的應用
    • 抑制因素
      • 奈米藥物的開發和商業化成本高昂
    • 機會
      • 新型奈米藥物開發策略聯盟
      • 奈米醫學研究和開發的有利資金形勢
    • 任務
      • 可用的臨床證據有限
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章以分子類型分類的奈米醫學市場

  • 奈米裝置
  • 奈米粒子
    • 樹狀聚合物
    • 水凝膠奈米顆粒
    • 無機奈米粒子
    • 脂質體
    • 金屬和金屬氧化物奈米粒子
    • 聚合物和聚合物藥物綴合物
  • 奈米殼
  • 奈米管

第7章 奈米醫學市場：依形式

  • 診斷
  • 過程

第8章奈米醫學市場：依應用分類

  • 診斷影像
  • 藥物輸送
  • 植入
  • 再生醫學
  • 疫苗

第9章 奈米醫學市場（按適應症）

  • 臨床循環系統
  • 臨床腫瘤學
  • 免疫學
  • 感染疾病
  • 神經病學
  • 眼科
  • 整形外科
  • 泌尿系統

第10章美洲奈米醫學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區奈米醫學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的奈米醫學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • AMAG Pharmaceuticals, Inc.
    • Amgen Inc.
    • Arrowhead Pharmaceuticals, Inc.
    • Bausch Health Companies Inc.
    • Bayer Healthcare
    • Biogen Inc.
    • Bristol-Myers Squibb Company
    • Celgene Corporation
    • Eisai Co Ltd
    • F. Hoffmann-La Roche AG
    • Galen Ltd
    • General Electric Company
    • Gilead Sciences, Inc.
    • Ipsen SA
    • Jazz Pharmaceuticals plc
    • Lantheus Holdings, Inc.
    • Leadient BioSciences Inc.
    • Mallinckrodt Pharmaceuticals
    • Merck & Co., Inc.
    • Nano spectra Biosciences, Inc.
    • Novo Nordisk A/S
    • OSARTIS GmbH
    • Pacira BioSciences Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Taiwan Liposome Company, Ltd.
    • Takeda Pharmaceutical Company Limited
    • Teva Pharmaceuticals Ltd.
    • UCB SA
    • Zimmer Biomet Holdings, Inc.
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-C002B1C9958A

[180 Pages Report] The Nanomedicine Market size was estimated at USD 206.25 billion in 2023 and expected to reach USD 227.37 billion in 2024, at a CAGR 10.91% to reach USD 425.88 billion by 2030.

Global Nanomedicine Market

KEY MARKET STATISTICS
Base Year [2023] USD 206.25 billion
Estimated Year [2024] USD 227.37 billion
Forecast Year [2030] USD 425.88 billion
CAGR (%) 10.91%
Nanomedicine Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Nanomedicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nanomedicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Nanomedicine Market, highlighting leading vendors and their innovative profiles. These include AMAG Pharmaceuticals, Inc., Amgen Inc., Arrowhead Pharmaceuticals, Inc., Bausch Health Companies Inc., Bayer Healthcare, Biogen Inc., Bristol-Myers Squibb Company, Celgene Corporation, Eisai Co Ltd, F. Hoffmann-La Roche AG, Galen Ltd, General Electric Company, Gilead Sciences, Inc., Ipsen SA, Jazz Pharmaceuticals plc, Lantheus Holdings, Inc., Leadient BioSciences Inc., Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Nano spectra Biosciences, Inc., Novo Nordisk A/S, OSARTIS GmbH, Pacira BioSciences Inc., Pfizer Inc., Sanofi S.A., Taiwan Liposome Company, Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Ltd., UCB SA, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Nanomedicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Molecule Type
    • Nanodevices
    • Nanoparticles
      • Dendrimers
      • Hydrogel Nanoparticles
      • Inorganic Nanoparticles
      • Liposomes
      • Metal & Metal Oxide Nanoparticles
      • Polymers & Polymer Drug Conjugates
    • Nanoshells
    • Nanotubes
  • Modality
    • Diagnostics
    • Treatment
  • Application
    • Diagnostic Imaging
    • Drug Delivery
    • Implants
    • Regenerative Medicine
    • Vaccines
  • Indication
    • Clinical Cardiology
    • Clinical Oncology
    • Immunology
    • Infectious Diseases
    • Neurology
    • Ophthalmology
    • Orthopedics
    • Urology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Nanomedicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nanomedicine Market?

3. What are the technology trends and regulatory frameworks in the Nanomedicine Market?

4. What is the market share of the leading vendors in the Nanomedicine Market?

5. Which modes and strategic moves are suitable for entering the Nanomedicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Nanomedicine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for efficient treatment
      • 5.1.1.2. Utilization of nanomedicine technology for personalized medicine
      • 5.1.1.3. Applications in vitro diagnostics and in vivo imaging
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development and commercialization of nanomedicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Strategic alliances for development of novel nanomedicine
      • 5.1.3.2. Favorable funding landscape for research and development of nanomedicine
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of clinical evidence
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Nanomedicine Market, by Molecule Type

  • 6.1. Introduction
  • 6.2. Nanodevices
  • 6.3. Nanoparticles
    • 6.4.1. Dendrimers
    • 6.4.2. Hydrogel Nanoparticles
    • 6.4.3. Inorganic Nanoparticles
    • 6.4.4. Liposomes
    • 6.4.5. Metal & Metal Oxide Nanoparticles
    • 6.4.6. Polymers & Polymer Drug Conjugates
  • 6.4. Nanoshells
  • 6.5. Nanotubes

7. Nanomedicine Market, by Modality

  • 7.1. Introduction
  • 7.2. Diagnostics
  • 7.3. Treatment

8. Nanomedicine Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Imaging
  • 8.3. Drug Delivery
  • 8.4. Implants
  • 8.5. Regenerative Medicine
  • 8.6. Vaccines

9. Nanomedicine Market, by Indication

  • 9.1. Introduction
  • 9.2. Clinical Cardiology
  • 9.3. Clinical Oncology
  • 9.4. Immunology
  • 9.5. Infectious Diseases
  • 9.6. Neurology
  • 9.7. Ophthalmology
  • 9.8. Orthopedics
  • 9.9. Urology

10. Americas Nanomedicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Nanomedicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Nanomedicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AMAG Pharmaceuticals, Inc.
    • 14.1.2. Amgen Inc.
    • 14.1.3. Arrowhead Pharmaceuticals, Inc.
    • 14.1.4. Bausch Health Companies Inc.
    • 14.1.5. Bayer Healthcare
    • 14.1.6. Biogen Inc.
    • 14.1.7. Bristol-Myers Squibb Company
    • 14.1.8. Celgene Corporation
    • 14.1.9. Eisai Co Ltd
    • 14.1.10. F. Hoffmann-La Roche AG
    • 14.1.11. Galen Ltd
    • 14.1.12. General Electric Company
    • 14.1.13. Gilead Sciences, Inc.
    • 14.1.14. Ipsen SA
    • 14.1.15. Jazz Pharmaceuticals plc
    • 14.1.16. Lantheus Holdings, Inc.
    • 14.1.17. Leadient BioSciences Inc.
    • 14.1.18. Mallinckrodt Pharmaceuticals
    • 14.1.19. Merck & Co., Inc.
    • 14.1.20. Nano spectra Biosciences, Inc.
    • 14.1.21. Novo Nordisk A/S
    • 14.1.22. OSARTIS GmbH
    • 14.1.23. Pacira BioSciences Inc.
    • 14.1.24. Pfizer Inc.
    • 14.1.25. Sanofi S.A.
    • 14.1.26. Taiwan Liposome Company, Ltd.
    • 14.1.27. Takeda Pharmaceutical Company Limited
    • 14.1.28. Teva Pharmaceuticals Ltd.
    • 14.1.29. UCB SA
    • 14.1.30. Zimmer Biomet Holdings, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NANOMEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. NANOMEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NANOMEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NANOMEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NANOMEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NANOMEDICINE MARKET DYNAMICS
  • FIGURE 7. NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NANOMEDICINE MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 10. NANOMEDICINE MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NANOMEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. NANOMEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. NANOMEDICINE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 14. NANOMEDICINE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NANOMEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES NANOMEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. NANOMEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. NANOMEDICINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NANOMEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NANOMEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NANOMEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. NANOMEDICINE MARKET SIZE, BY NANODEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 9. NANOMEDICINE MARKET SIZE, BY DENDRIMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NANOMEDICINE MARKET SIZE, BY HYDROGEL NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NANOMEDICINE MARKET SIZE, BY INORGANIC NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NANOMEDICINE MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NANOMEDICINE MARKET SIZE, BY METAL & METAL OXIDE NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NANOMEDICINE MARKET SIZE, BY POLYMERS & POLYMER DRUG CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NANOMEDICINE MARKET SIZE, BY NANOSHELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NANOMEDICINE MARKET SIZE, BY NANOTUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 18. NANOMEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NANOMEDICINE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. NANOMEDICINE MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NANOMEDICINE MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NANOMEDICINE MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. NANOMEDICINE MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. NANOMEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. NANOMEDICINE MARKET SIZE, BY CLINICAL CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. NANOMEDICINE MARKET SIZE, BY CLINICAL ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. NANOMEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. NANOMEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. NANOMEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. NANOMEDICINE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. NANOMEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. NANOMEDICINE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NANOMEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES NANOMEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NANOMEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 245. NANOMEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 246. NANOMEDICINE MARKET LICENSE & PRICING